Power up your business with FlexBeam

With high metabolic rate, this stage is ENERGY demanding.

Red and infrared light therapy enhance local circulation of nitric oxide (NO), electron transport, stimulates mitochondrial respiration, and increases ATP production. Concurrently, there is an elevation in Mitochondrial Membrane Potential (MMP), resulting in a tangible increase in energy generation. Galvanotaxis facilitates active healing at the cellular level, while active angiogenesis contributes to faster healing.

During this stage, there is an integration of damaged tissues and scar formation.

Red and infrared light therapy activates stem precursor cells, satellite cells and enables cellular proliferation, increasing collagen production and decreasing collagen degradation. There is a proliferation of fibroblasts and faster conversion from Collagen III to Collagen I.

During this stage, fibroblasts, myoblasts, osteoblasts, and other stem cells are activated to repair damage, form new functional tissues, and contract and reorganize scars. Red and infrared light therapy are known to accelerate the remodelling of scar tissue and promote the regeneration of nerve cells.

FlexBeam dimensions are 35cm x 13.5cm x 4cm. The 3 light modules plus one battery module are connected by a flexible silicon material allowing the device to be wrapped around a limb. In addition, it can be or secured flat against the body by using the provided straps, where necessary. This enables treatment on any area of the body and, in the case of wrapping around a limb, treatment from multiple angles.

The device is comprised of 6 Near infrared (NIR) LEDs at 810-830 nm (3 modules, 2 LEDs/module) and 3 red LEDs at 625-635nm (3 modules, 1 LED/module). The LEDs are high quality with a 90-245V AC input power supply with 15V, 2.4A output. Peak wavelength 630 nm in red and 815 nm in near-infrared. When in contact, it irradiates 9 cm2 of skin per module, a total of 81 cm2.

The key technical parameters of FlexBeam were calculated with a consideration of fluence, dose of energy and bi-phasic dose response. When in contact with skin, FlexBeam has a maximum power output of 100mW/cm2 in the NIR LEDs and 50mW/cm2 in the red LEDs. The device operates in pulsing mode with pulsing frequencies between 10-1000 Hz and duty cycle of 10-100% with 10-minute intervention time. All materials in direct contact with the skin meet ISO 10993 requirements for bio-compatibility for cytotoxicity, sensitisation, and irritation.

FlexBeam is powered by a rechargeable Li-ion battery contained in the battery module with one charge lasting for up to 1.5 hours. This module also contains the user interface for turning on and shutting down the device, program selection and indication of battery life.

The device contains an active fan cooling system to regulate temperature and automatic shutdown at the completion of each treatment. It is also programmed to shut down in the case of overheating or overcurrent faults to ensure user safety.

The FlexBeam is intended to be used directly on the skin, anywhere on the body. It is not designed to treat the head. It’s an over-the-counter device intended for the temporary relief of minor muscle and joint pain, arthritis and muscle spasm; relieving stiffness; temporary relaxation of muscle tissue and to temporarily increase local blood circulation.

FlexBeam emits non-coherent red and near-infrared (NIR) light, and its effects are accomplished through an optimization of mitochondria functioning and an increase in microcirculation stimulated by this light.

Additional associated benefits are faster recovery rate from physical performance, increased energy level, and improvement of general wellbeing and sleep.